EP2912161A4 - Procédés et systèmes pour estimer les besoins nutritionnels de patients humains et d'autres patients et pour prendre en charge de tels besoins nutritionnels - Google Patents
Procédés et systèmes pour estimer les besoins nutritionnels de patients humains et d'autres patients et pour prendre en charge de tels besoins nutritionnelsInfo
- Publication number
- EP2912161A4 EP2912161A4 EP13848522.2A EP13848522A EP2912161A4 EP 2912161 A4 EP2912161 A4 EP 2912161A4 EP 13848522 A EP13848522 A EP 13848522A EP 2912161 A4 EP2912161 A4 EP 2912161A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- nutritional needs
- patients
- human
- systems
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/42—Phosphorus; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19151852.1A EP3505167A1 (fr) | 2012-10-25 | 2013-10-24 | Prendre en charge les besoins nutritionnels de l'homme et d'autres patients |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261795819P | 2012-10-25 | 2012-10-25 | |
US13/903,936 US9557334B2 (en) | 2012-10-25 | 2013-05-28 | Formulations and methods to provide nutrition to human and other patients |
US13/903,939 US9500657B2 (en) | 2012-10-25 | 2013-05-28 | Formulations containing labels for medical diagnostics |
US13/903,929 US9808031B2 (en) | 2012-10-25 | 2013-05-28 | Systems and methods to estimate nutritional needs of human and other patients |
US13/957,813 US8927490B2 (en) | 2012-10-25 | 2013-08-02 | Systems and methods to estimate nutritional needs of human and other patients |
US13/957,977 US20140120238A1 (en) | 2012-10-25 | 2013-08-02 | Formulations and methods to provide nutrition to human and other patients |
US13/957,872 US20140121270A1 (en) | 2012-10-25 | 2013-08-02 | Formulations and methods to provide nutrition to human and other patients |
US14/043,703 US9232815B2 (en) | 2012-10-25 | 2013-10-01 | Blood lactate range targets and nutritional formulations and protocols to support patients |
US14/061,640 US9897609B2 (en) | 2012-10-25 | 2013-10-23 | Systems and apparatus to estimate nutritional needs of human and other patients and to support such nutritional needs |
PCT/US2013/066597 WO2014066628A2 (fr) | 2012-10-25 | 2013-10-24 | Procédés et systèmes pour estimer les besoins nutritionnels de patients humains et d'autres patients et pour prendre en charge de tels besoins nutritionnels |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19151852.1A Division EP3505167A1 (fr) | 2012-10-25 | 2013-10-24 | Prendre en charge les besoins nutritionnels de l'homme et d'autres patients |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2912161A2 EP2912161A2 (fr) | 2015-09-02 |
EP2912161A4 true EP2912161A4 (fr) | 2016-08-24 |
Family
ID=53056453
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP13848522.2A Ceased EP2912161A4 (fr) | 2012-10-25 | 2013-10-24 | Procédés et systèmes pour estimer les besoins nutritionnels de patients humains et d'autres patients et pour prendre en charge de tels besoins nutritionnels |
EP19151852.1A Withdrawn EP3505167A1 (fr) | 2012-10-25 | 2013-10-24 | Prendre en charge les besoins nutritionnels de l'homme et d'autres patients |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19151852.1A Withdrawn EP3505167A1 (fr) | 2012-10-25 | 2013-10-24 | Prendre en charge les besoins nutritionnels de l'homme et d'autres patients |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP2912161A4 (fr) |
JP (2) | JP2016502654A (fr) |
KR (1) | KR102172971B1 (fr) |
AU (2) | AU2013334526B2 (fr) |
CA (1) | CA2889348A1 (fr) |
WO (1) | WO2014066628A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20170156386A1 (en) * | 2014-05-21 | 2017-06-08 | Nestec S.A. | System, process and device for producing a nutritional composition with personalized nutrient content |
US10768169B2 (en) * | 2015-01-23 | 2020-09-08 | Societe Des Produits Nestle S.A. | Method for determining the distinctive nutritional requirements of a patient |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080275136A1 (en) * | 2005-05-25 | 2008-11-06 | Alain Grynberg | Use of Glycerol for Improving Cardiac Function |
US20090285909A1 (en) * | 2006-04-03 | 2009-11-19 | Leverve Xavier M | Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5420107A (en) | 1990-01-26 | 1995-05-30 | Brooks; George A. | Method and composition for energy source supplementation during exercise and recovery |
US5910403A (en) * | 1997-05-15 | 1999-06-08 | The Regents Of University Of California | Methods for measuring cellular proliferation and destruction rates in vitro and in vivo |
US6329208B1 (en) * | 1997-07-16 | 2001-12-11 | Board Of Regents, The University Of Texas System | Methods for determining gluconeogenesis, anapleurosis and pyruvate recycling |
US6482853B1 (en) | 2000-07-12 | 2002-11-19 | George A. Brooks | Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery |
US7256047B2 (en) * | 2001-05-01 | 2007-08-14 | Board Of Regents, The University Of Texas System | Measurement of gluconeogenesis and intermediary metabolism using stable isotopes |
CA2457523A1 (fr) * | 2001-08-06 | 2003-08-14 | Vanderbilt University | Appareil et procedes permettant de discriminer un agent a l'aide de matiere biologique |
MY135783A (en) * | 2001-09-07 | 2008-06-30 | Meiji Dairies Corp | Nutritional composition for controlling blood sugar level |
WO2004011426A2 (fr) * | 2002-07-30 | 2004-02-05 | The Regents Of The University Of California | Procede de mesure automatique a grande echelle des taux de flux moleculaire proteomique ou organeomique par spectrometrie de masse |
US20050027005A1 (en) * | 2003-08-02 | 2005-02-03 | Matthias Boldt | Nutrient compositions and methods for sustenance and promotion of positive metabolic energy levels in a targeted manner |
WO2006119355A2 (fr) * | 2005-05-03 | 2006-11-09 | Albert Einstein College Of Medicine Of Yeshiva University | Modulation hypothalamique du metabolisme du glucose chez les mammiferes par l'intermediaire de nutriments |
US7503937B2 (en) * | 2006-07-03 | 2009-03-17 | Ossur Hf | Prosthetic foot |
CN101939011B (zh) * | 2008-02-07 | 2012-10-10 | 雀巢产品技术援助有限公司 | 用于影响由剧烈的体力活动中恢复的组合物和方法 |
-
2013
- 2013-10-24 WO PCT/US2013/066597 patent/WO2014066628A2/fr active Application Filing
- 2013-10-24 JP JP2015539789A patent/JP2016502654A/ja active Pending
- 2013-10-24 KR KR1020157013573A patent/KR102172971B1/ko active IP Right Grant
- 2013-10-24 EP EP13848522.2A patent/EP2912161A4/fr not_active Ceased
- 2013-10-24 CA CA2889348A patent/CA2889348A1/fr not_active Abandoned
- 2013-10-24 EP EP19151852.1A patent/EP3505167A1/fr not_active Withdrawn
- 2013-10-24 AU AU2013334526A patent/AU2013334526B2/en not_active Ceased
-
2018
- 2018-09-12 AU AU2018229477A patent/AU2018229477A1/en not_active Abandoned
-
2020
- 2020-02-04 JP JP2020017024A patent/JP2020101549A/ja active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080275136A1 (en) * | 2005-05-25 | 2008-11-06 | Alain Grynberg | Use of Glycerol for Improving Cardiac Function |
US20090285909A1 (en) * | 2006-04-03 | 2009-11-19 | Leverve Xavier M | Lactate and Calcium Containing Pharmaceutical Composition and Uses Thereof |
Non-Patent Citations (8)
Title |
---|
BOUZAT PIERRE ET AL: "Cerebral metabolic effects of exogenous lactate supplementation on the injured human brain.", INTENSIVE CARE MEDICINE MAR 2014, vol. 40, no. 3, March 2014 (2014-03-01), pages 412 - 421, XP009191029, ISSN: 1432-1238 * |
C. BERGER ET AL: "Neurochemical Monitoring of Glycerol Therapy in Patients With Ischemic Brain Edema", STROKE, vol. 36, no. 2, 1 February 2005 (2005-02-01), US, pages e4 - e6, XP055289143, ISSN: 0039-2499, DOI: 10.1161/01.STR.0000151328.70519.e9 * |
CAROLE BERTHET ET AL: "Neuroprotective role of lactate after cerebral ischemia", JOURNAL OF CEREBRAL BLOOD FLOW & METABOLISM, vol. 29, no. 11, 1 November 2009 (2009-11-01), US, pages 1780 - 1789, XP055288957, ISSN: 0271-678X, DOI: 10.1038/jcbfm.2009.97 * |
HOLLOWAY R ET AL: "Effect of lactate therapy upon cognitive deficits after traumatic brain injury in the rat", ACTA NEUROCHIRURGICA ; THE EUROPEAN JOURNAL OF NEUROSURGERY, SPRINGER-VERLAG, VI, vol. 149, no. 9, 30 July 2007 (2007-07-30), pages 919 - 927, XP019544456, ISSN: 0942-0940, DOI: 10.1007/S00701-007-1241-Y * |
KING P ET AL: "INTRAVENOUS LACTATE PREVENTS CEREBRAL DYSFUNCTION DURING HYPOGLYCAEMIA IN INSULIN-DEPENDENT DIABETES MELLITUS", CLINICAL SCIENCE, BIOCHEMICAL SOCIETY AND THE MEDICAL RESEARCH SOCIETY, LONDON, GB, vol. 94, no. 2, 1 February 1998 (1998-02-01), pages 157 - 163, XP009034382, ISSN: 0143-5221 * |
LARS W. ANDERSEN ET AL: "Etiology and Therapeutic Approach to Elevated Lactate Levels", MAYO CLINIC PROCEEDINGS, vol. 88, no. 10, 1 October 2013 (2013-10-01), US, pages 1127 - 1140, XP055288931, ISSN: 0025-6196, DOI: 10.1016/j.mayocp.2013.06.012 * |
THOMAS C. GLENN ET AL: "Endogenous Nutritive Support after Traumatic Brain Injury: Peripheral Lactate Production for Glucose Supply via Gluconeogenesis", JOURNAL OF NEUROTRAUMA., vol. 32, no. 11, 1 June 2015 (2015-06-01), US, pages 811 - 819, XP055288969, ISSN: 0897-7151, DOI: 10.1089/neu.2014.3482 * |
THOMAS C. GLENN ET AL: "Lactate: Brain Fuel in Human Traumatic Brain Injury: A Comparison with Normal Healthy Control Subjects", JOURNAL OF NEUROTRAUMA., vol. 32, no. 11, 1 June 2015 (2015-06-01), US, pages 820 - 832, XP055288968, ISSN: 0897-7151, DOI: 10.1089/neu.2014.3483 * |
Also Published As
Publication number | Publication date |
---|---|
WO2014066628A3 (fr) | 2014-08-28 |
EP2912161A2 (fr) | 2015-09-02 |
AU2018229477A1 (en) | 2018-10-04 |
JP2016502654A (ja) | 2016-01-28 |
KR20150076229A (ko) | 2015-07-06 |
AU2013334526B2 (en) | 2018-06-14 |
JP2020101549A (ja) | 2020-07-02 |
EP3505167A1 (fr) | 2019-07-03 |
WO2014066628A2 (fr) | 2014-05-01 |
AU2013334526A1 (en) | 2015-06-11 |
KR102172971B1 (ko) | 2020-11-03 |
CA2889348A1 (fr) | 2014-05-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2836270A4 (fr) | Systèmes et procédés liés au traitement de la douleur dorsale | |
EP2863858A4 (fr) | Systèmes de soutien pour patient et leurs procédés d'utilisation | |
IL242825B (en) | Systems and methods for diagnosis of depression and other medical conditions | |
HK1206037A1 (en) | Human antibodies to gfr3 and methods of use thereof gfr3 | |
IL239353A0 (en) | Continuous production unit and methods for using it | |
EP2811897A4 (fr) | Kiosque médical et son procédé d'utilisation | |
EP2967579A4 (fr) | Dispositifs tressés extensibles multicouche et procédés d'utilisation | |
EP2858610A4 (fr) | Système de thérapie thermique et procédé d'utilisation | |
EP2838444A4 (fr) | Dispositifs d'occlusion expansibles et procédés d'utilisation | |
EP2856421A4 (fr) | Systèmes et procédés pour la fourniture de traitement médical transparent | |
EP2906127A4 (fr) | Systèmes et procédés d'ancrage de dispositifs médicaux | |
GB201220219D0 (en) | System and method of image reconstruction | |
EP2912178A4 (fr) | Super-activateurs et procédés d'utilisation de ceux-ci | |
EP2873239A4 (fr) | Système de surveillance et procédés d'utilisation associés | |
EP2864004A4 (fr) | Dispositif à longueur de débattement adaptable, et procédé d'utilisation | |
GB2500588B (en) | Systems and methods of hyperthermal treatment | |
IL233746B (en) | A modular bioengineering and medical system | |
EP2825363A4 (fr) | Article médical flexible et son procédé de fabrication | |
GB201200948D0 (en) | Funeral urn system and method of using same | |
HK1207966A1 (en) | Dietary and nutritional compositions and methods of use | |
EP2931351A4 (fr) | Systèmes et procédés d'ancrage de dispositifs médicaux | |
GB201408351D0 (en) | Manufacture method and manufacture system of medical sleeve | |
HK1210008A1 (en) | Systems and methods for treatment of sleep apnea | |
EP2814413A4 (fr) | Élément de fixation d'os et ses procédés d'utilisation | |
HK1207953A1 (en) | An enhanced therapeutic stimulus system and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150522 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20160727 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 31/047 20060101AFI20160721BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20170329 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R003 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED |
|
18R | Application refused |
Effective date: 20190115 |